Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propionyl-L-carnitine in PAD (Intermittent Claudication)
NCT00809497Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- May 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of propionyl-L-carnitine in Peripheral Arterial Disease (PAD), intermittent claudication (IC), sponsored by Lee's Pharmaceutical Holdings Limited. Started May 2008; status: completed.
02
Drugs
propionyl-L-carnitine
03
Conditions
Peripheral Arterial Disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00809497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809497.